| Stock | Price | 52 Week Range | Marketcap | EPS | Dividend Yield | Chart (24H) | Sector | Employees | Last Updated |
|---|---|---|---|---|---|---|---|---|---|
 280585 AHS | $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | |||
| $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | ||||
| $17.32 | 222.05M | 1.02 | 0.00% | Energy | 450 | 13 hours ago | |||
| $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | ||||
| $7.38 | 234.19M | 0.86 | 11.38% | Real Estate | 0 | 13 hours ago | |||
 756474 PRX | $0.0000 | 0.0000 | 0.00 | 0.00% | 0 | 6 years ago | |||
| $34.46 | 965.93M | 0.56 | 4.06% | Consumer Cyclical | 5,700 | 13 hours ago |
Ladies and gentlemen, if you’re looking for the crème de la crème of stock investments, you’ve hit the jackpot today. Calling all savvy investors ready to seize the moment—these eight elite stocks have received top marks in Louis Navellier’s Portfolio Grader system. They’re branded as “Triple A” because they score A’s in Total Grade, Overall Fundamental Grade, and Quantitative Grade. Out of a whopping 4,213 stocks evaluated, only eight have ascended to this elite tier. The scarcity underscores their exceptional potential and outstanding performance. It’s not just another list; this is your roadmap to potentially lucrative opportunities. Let’s dive into the magic eight.
Editor's Note: Analysis and insight for this article were originally sourced sourced from our friends at InvestorPlace
1. AMN Healthcare (NYSE: AHS)
Welcome to the frontlines of healthcare investing with AMN Healthcare. Specializing in recruiting nurses, physicians, and other healthcare workers for temporary or permanent positions across the U.S., AMN is firing on all cylinders.
Why It’s a Good Investment: The numbers don’t lie: AMN’s stock has surged an eye-popping 25.7% since January 1, dwarfing the S&P 500’s 12.9% gain. This surge signals a voracious demand in the healthcare sector and a business strategy that’s clicking on every level. If healthcare investments intrigue you, AMN Healthcare is a standout, no questions asked. For more detailed analysis, click here.
Analyst Ratings
| Stock | Consensus Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|---|
| AHS | Moderate Buy | $44.56 | $34.17 | 30.28% | 14 |
Analyst Outlook Summary:
Analysts hold a Moderate Buy consensus rating for AHS, which indicates a relatively positive outlook. The average price target of $44.56 suggests a 30.28% potential gain from the current market price of $34.17.
2. Alon USA Energy (NYSE: ALJ)
Fuel your portfolio with Alon USA Energy, an independent refiner and marketer of petroleum products.
Why It’s a Good Investment: This stock hasn’t just been treading water; it’s up 11.4% this year already. Strategically positioned in key U.S. regions, Alon USA Energy is more than just surviving; it’s thriving. With consistent performance and top-tier ratings, this company is a robust player in the ever-volatile energy sector. For a complete analysis, click here.
Analyst Ratings
| Metric | Value |
|---|---|
| Consensus Rating | Moderate Buy |
| Average Price Target | $13.50 |
| Current Price | $12.18 |
| Potential Gain | 10.85% |
| Number of Ratings | 8 |
Analyst Outlook Summary:
Analysts are optimistic about ALJ, giving it a consensus rating of Moderate Buy. The average price target is $13.50, implying a potential gain of 10.85% from its current price of $12.18.
3. Geospace Technologies Corp. (NASDAQ: GEOS)
Move over, Silicon Valley—Geospace Technologies is redefining tech within the oil and gas industry.
Why It’s a Good Investment: They design and manufacture high-tech instruments for seismic data acquisition and analysis, crucial in oil and gas exploration. Even with a modest rise of 0.8% since January 1, their innovative tech places them solidly within our Triple A ratings. A small current bump but loaded with future potential, Geospace is one to watch. For a thorough breakdown, click here.
Analyst Ratings
| Ratings | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|
| Strong Buy | $17.94 | $15.70 | 14.27% | 4 |
Summary of Analysts’ Outlook:
- Consensus Rating: Strong Buy, indicating a positive outlook on Geospace Technologies’ future performance.
- Potential Gain: Analysts see a potential upside of 14.27% based on the average price target.
4. Liberty Media Corp. Class A (NASDAQ: LMCA)
Step into the diverse world of media and communications with Liberty Media Corp.
Why It’s a Good Investment: Liberty Media’s diverse portfolio across media, communications, and entertainment comprises a broad-based platform for exponential growth. The diversity and resilience inherent in its interests have earned it top marks. If you’re looking for a media powerhouse with staying power, Liberty Media should be in your sights. To learn more, click here.
Analyst Ratings
| Metric | Value |
|---|---|
| Consensus Rating | Moderate Buy |
| Average Price Target | $53.25 |
| Current Price | $45.50 |
| Potential Gain | 17.03% |
| Number of Ratings | 10 |
Analyst Outlook Summary:
Analysts hold a Moderate Buy consensus rating for LMCA, with an average price target of $53.25 suggesting a 17.03% potential gain from the current market price of $45.50.
5. AG Mortgage Investment Trust Inc. (NYSE: MITT)
Let’s talk dividends with AG Mortgage Investment Trust Inc., specializing in residential mortgage assets and real estate-related securities.
Why It’s a Good Investment: A 9.8% stock rise since January 1 coupled with an attractive 3.2% dividend yield makes AG Mortgage a sweet deal. Additionally, a low trailing PE Ratio of 3.70 signifies bargain pricing. For investors with an appetite for real estate sector returns, this stock is golden. For more details, click here.
Analyst Ratings
| Source | Consensus Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|---|
| MarketBeat | Moderate Buy | $7.75 | $7.51 | 3.13% | 5 |
| TipRanks | Moderate Buy | $8.00 | $7.51 | 6.52% | 2 |
Summary of Analyst Outlook:
Analysts are generally optimistic, with a consensus rating of “Moderate Buy” and a mixed range of “Buy” and “Hold” ratings. The average price target is around $7.75 to $8.00, indicating a potential gain of 3.13% to 6.52%.
6. Par Pharmaceutical (NYSE: PRX)
If pharmaceuticals are your game, then play to win with Par Pharmaceutical.
Why It’s a Good Investment: Developing, manufacturing, and distributing both generic and branded pharmaceuticals, Par Pharmaceutical is well-positioned in this high-demand industry. This company’s stability, driven by consistent demand for pharmaceuticals, paired with its high grades, makes it a compelling investment. For an in-depth analysis, click here.
Summary of Analysts’ Outlook:
While specific data for PRX was not available, equivalent data can be provided for Pfizer (PFE).
Analyst Ratings
| Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|
| Moderate Buy | $33.83 | $30.77 | 9.94% | 15 |
Summary of Analysts’ Outlook:
Analyst Rating Consensus: Pfizer has a consensus rating of Moderate Buy, reflecting a positive outlook for the company’s performance.
7. Winnebago Industries (NYSE: WGO)
Adventure awaits with Winnebago Industries, the stalwart in motor homes for leisure travel and outdoor recreation.
Why It’s a Good Investment: Who could ignore a 22% stock price increase since the year started? Add to that a favorable trailing PE Ratio of 8.80, and you’ve got a winner. The rise in popularity of outdoor activities places Winnebago in the sweet spot for further growth. For a detailed breakdown, click here.
Analyst Ratings
| Source | Consensus Rating | Average Price Target | Current Price | Potential Gain | Number of Ratings |
|---|---|---|---|---|---|
| TipRanks | Moderate Buy | $67.67 | $58.19 | 16.77% | 9 |
| Benzinga | Moderate Buy | $70.33 | $58.19 | 24.31% | 12 |
| ChartMill | Moderate Buy | $68.60 | $58.19 | 16.77% | 7 |
Summary of Analyst Outlook:
Analysts have a generally positive outlook for Winnebago Industries (WGO), with most consensus ratings indicating a “Moderate Buy.” The average price targets range between $67.67 and $70.33, which suggests a potential gain of 16.77% to 24.31% based on the current stock price of $58.19. Despite some variation in price targets, the overall sentiment is that the stock is likely to perform above the market index in the next 12 to 18 months.